Small molecules with structure-based designs and synthesis are our professional skills. We deliver our expertise in drug developments by several approaches:

1. New salts (organic and inorganic) to improve the existing drugs.

2. New formulations to improve the existing drugs.

3. New route of administration to improve the existing drugs for therapy.

4. Structural modifications as prodrugs to improve the existing drugs.

5. New molecular entity designs based on structural information and synthesis to create new drugs for unmet medical needs.